A2 Awardees

The national a2 Pilot Awards competition is hosted annually by the a2 Collective and funded by the National Institute on Aging (NIA), part of the National Institutes of Health, through the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program.

NIA has earmarked $40 million to fund demonstration technology projects that utilize artificial intelligence (AI) approaches and technology to improve care and health outcomes for older Americans, including persons with Alzheimer’s disease and related dementias (AD/ADRD) and their caregivers. Selected existing awardees are listed here.

View Resource

A2 Collective Youtube Channel

The AI/Tech + Aging Pilot Awards (a2 Pilot Awards) is a national competition hosted by the a2 Collective and funded by the National Institute on Aging (NIA) through its Artificial Intelligence and Technology Collaboratories for Aging Research (AITC) program.
The NIA has earmarked $40 million over the next 5 years to fund demonstration projects that utilize artificial intelligence approaches and technology to improve care and health outcomes for older Americans, including persons with Alzheimer’s Disease and Related Dementia (AD/ADRD) and their caregivers.

We share a2 Collective videos (e.g., webinars, call for applications) in this youtube channel.

View Resource

A2 National Symposium 2023

The a2 Collective represents the National Institute on Aging (NIA) Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program, which is dedicated to helping Americans live longer, healthier lives through the application of artificial intelligence (AI) and emerging technologies. The a2 Collective comprises three AITCs centered at Johns Hopkins University, the University of Massachusetts Amherst, and the University of Pennsylvania and the a2 Collective Coordinating Center managed by Rose Li & Associates, Inc.

The a2 Collective is organizing a national symposium to be held on March 8, 2023, in Baltimore, MD, on the campus of the Johns Hopkins University School of Medicine. 

View Resource

A2Collective Events

The a2 Collective represents the National Institute on Aging (NIA) Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program, which is dedicated to helping Americans live longer, healthier lives through the application of artificial intelligence (AI) and emerging technologies. The a2 Collective comprises three AITCs centered at Johns Hopkins University, the University of Massachusetts Amherst, and the University of Pennsylvania and the a2 Collective Coordinating Center managed by Rose Li & Associates, Inc.

The a2 Collective is organizing a series of events, including call for proposals, symposia, webinars, etc. 

View Resource

A2Collective Home

The a2 Collective represents the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program, which is dedicated to helping Americans live longer, healthier lives through the application of artificial intelligence (AI) and emerging technologies.

The AITC program has earmarked $40M to fund promising AI technology pilot projects that seek to improve care and health outcomes for older Americans, including persons with Alzheimer’s disease and related dementias (AD/ADRD). Pilot awardees may receive access to the study sites, datasets, and resources at each AITC as well as mentorship from industry and university experts, major healthcare systems, and venture capitalists.

The AITC program is funded by the National Institute on Aging (NIA), part of the National Institutes of Health.

View Resource

A2Collective Pilot Awards

The national a2 Pilot Awards competition is hosted annually by the a2 Collective and funded by the National Institute on Aging (NIA), part of the National Institutes of Health, through the Artificial Intelligence and Technology Collaboratories (AITC) for Aging Research program.

NIA has earmarked $40 million to fund demonstration technology projects that utilize artificial intelligence (AI) approaches and technology to improve care and health outcomes for older Americans, including persons with Alzheimer’s disease and related dementias (AD/ADRD) and their caregivers.

View Resource